Organigram Holdings (TSXV:OGI) announced an update to its compassionate care model to create a program to allow medical cannabis for low-income patients.
As quoted in the press release:
Effective immediately, patients who earn an annual income less than [C]$35,000 per year qualify for OrganiCare, the Company’s new program that offers qualified patients a 30 per cent price reduction on all dried cannabis products and oils.
Previously, compassionate pricing was offered to individuals earning less than [C]$30,000 per year and offered a 25 per cent price reduction.
“We understand cost can be a barrier to medication for patients,” says Greg Engel, CEO, Organigram. “It is important to us to do what we can to improve access for patients who need it the most. It’s our hope that OrganiCare will allow a greater number of patients to access their medicine.”